Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Dare Bioscience Inc (DARE) USD0.0001

Sell:$1.00 Buy:$1.06 Change: $0.02 (2.00%)
NASDAQ:0.37%
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:$1.00
Buy:$1.06
Change: $0.02 (2.00%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:$1.00
Buy:$1.06
Change: $0.02 (2.00%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.

Contact details

Address:
3655 Nobel Dr Ste 260
SAN DIEGO
92122-1050
United States
Telephone:
+1 (858) 9267655
Website:
https://www.darebioscience.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DARE
ISIN:
US23666P1012
Market cap:
$26.91 million
Shares in issue:
28.52 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • William Rastetter
    Independent Chairman of the Board
  • Sabrina Johnson
    President, Chief Executive Officer, Secretary, Director
  • Gregg Beloff
    Principal Financial Officer
  • Lisa Walters-Hoffert
    Chief Financial Officer
  • Jame O'Neill
    Principal Accounting Officer, Controller, Assistant Treasurer
  • John Fair
    Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.